Tga nimenrix product information

Author: pvss

August undefined, 2024

WebNimenrix is a meningococcal conjugate vaccine to protect against meningococcal groups A, C, W and Y. In New Zealand, Nimenrix is only available as a purchased vaccine for individuals from 6 weeks of age through your family doctor. WebNimenrix is the first quadrivalent conjugate vaccine to be approved in Europe for active immunisation of individuals from 12 months of age against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W -135 and Y. Nimenrix is provided as one dose and is generally well tolerated.

Package leaflet: Information for the user Nimenrix powder and

WebNimenrix more than approximately one year previously, consideration may be given to administering a second dose. Available data indicate that a second dose will elicit an … WebNIMENRIX is a vaccine used to help prevent meningococcal disease, caused by four types of Neisseria meningitides bacteria (types A, C, W and Y). NIMENRIX works by causing your body to produce its own protection (or antibodies), against these types of meningococcal bacteria. NIMENRIX cannot cause meningococcal disease. thiersbach

Nimenrix European Medicines Agency

Web10 Mar 2024 · Nimenrix powder and solvent for solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) by Pfizer Limited ... Find similiar products: Same active … WebThe company that markets Nimenrix will carry out a study to assess how long the protective immune response provided by one or two doses of Nimenrix lasts in young children … Web5 May 2024 · You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or … thiers automobiles occasion

Nimenrix (meningococcal group A, C, W-135 and Y conjugate …

Web5 Apr 2024 · The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice on the introduction of meningococcal ACWY vaccine (Nimenrix®) for adolescents through the National Immunisation Program (NIP). It includes information about: recommendations for the use of meningococcal ACWY vaccine WebNPS MedicineWise thiers avisWebThe product information for MenQuadfi, Menveo and Nimenrix state that vaccine should be administered as a single dose to people aged ≥2 years. ATAGI recommends that these … thiers auvergne foot

"Web2. What you need to know before you receive Nimenrix 3. How Nimenrix is given 4. Possible side effects 5. How to store Nimenrix 6. Contents of the pack and other information . 1. What Nimenrix is and what it is used for . What Nimenrix is and what it is used for . Nimenrix is a vaccine which helps protect against infections caused by bacteria ... " - Tga nimenrix product information

Tga nimenrix product information

Nimenrix: Uses, Side Effects, Benefits/Risks Drugs.com

WebQuadrivalent meningococcal conjugate vaccines Description: Registered for use in people aged ≥6 weeks. MenACWY -TT — quadrivalent meningococcal (serogroups A, C, W, … WebNimenrix™ Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine 1. NAME OF THE MEDICINAL PRODUCT Nimenrix™ 2. QUALITATIVE AND QUANTITATIVE …

Did you know?

WebNIMENRIX is a vaccine used to help prevent meningococcal disease, caused by four types of Neisseria meningitidis bacteria (types A, C, W and Y). NIMENRIX works by causing your body to produce... Web6. Contents of the pack and other information 1. What Nimenrix is and what it is used for What Nimenrix is and what it is used for Nimenrix is a vaccine which helps protect …

WebNimenrix is indicated for active immunisation of individualsfrom the age of 12 months and above against invasive meningococcal diseases causedby Neisseria meningitidisgroup A, … WebNimenrix™may be givenas a booster doseto individualswho have previouslyreceived primary vaccination with Nimenrix™or other conjugated or plain polysaccharide …

WebSanofi Pasteur Product Monograph 284 – Menactra® Page 4 of 42 Menactra® Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate …

WebNIMENRIX ® is for intramuscular injection only. 2. In infants, the recommended injection site is the anterolateral aspect of the thigh. In individuals from 1 year of age, the …

WebΤο Nimenrix θα πρέπει να χορηγείται προσεκτικά σε άτομα με θρομβοπενία ή οποιαδήποτε διαταραχή πηκτικότητας, καθώς μπορεί να επακολουθήσει αιμορραγία μετά από ενδομυϊκή … thiers biographieWeb22 Jun 2015 · Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine) is a single dose meningococcal ACWY-TT (tetanus toxoid) conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. thiers birch razorWebNIMENRIX against the possible risks. If you have any questions about NIMENRIX, ask your doctor, nurse or pharmacist. Keep this leaflet. You may need to read it again. What NIMENRIX is used for NIMENRIX is a vaccine used to help prevent meningococcal disease, caused by four types of Neisseria meningitidis bacteria (types A, C, W and Y). saint asonia - introvertWebPI & CMI Trade Names and Active Ingredients containing infanrix hexa. 1 Documents available. Need more information on a product? Search the Australian Register of … thiers arcachonWebWhat Nimenrix is and what it is used for. Nimenrix is a vaccine which helps protect against infections caused by bacteria (germs) called “Neisseria meningitidis" types A, C, W-135 … saint asonia happy hourWebFor Product Information and Consumer Medicine Information about Priorix-tetra visit the Therapeutic Goods Administration website. Additional vaccine information. For detailed … saint asonia happy tragedy lyricsWeb30 May 2024 · Nimenrix Active Ingredient: meningococcal groups A, C, W-135 and Y conjugate vaccine Company: Pfizer Limited See contact details About Medicine … saint asonia starland ballroom